SITC Resource Library

On January 13, 2022, leading experts from the SITC HNSCC Immunotherapy Guideline Expert Panel presented "Practical Management Pearls for Immunotherapy for the Treatment of HNSCC — SITC CPG Webinar." This high-level webinar was designed to teach attendees how to appraise and classify organ-specific considerations for immunotherapy agents and toxicities, identify and manage clinically significant uncommon toxicities, and determine optimal sequencing of immunotherapies in relapsed and/or refractory disease, as discussed in the Clinical Practice Guideline (CPG). The recorded webinar and presentation slides are available below.

Webinar Faculty:

• Co-Moderator: Robert L. Ferris, MD, PhD – University of Pittsburgh Medical Center (Expert Panel Chair)
  
• Co-Moderator: Nancy Y. Lee, MD – Memorial Sloan Kettering Cancer Center (Expert Panel Member)
• Barbara A. Burtness, MD – Yale University School of Medicine (Expert Panel Member)
• Kevin J. Harrington, MBBCh, PhD, FRCP, FRCR – The Institute of Cancer Research, London (Expert Panel Member)
• Rebecca L. Lewis, CRNP – UPMC Hillman Cancer Center (Expert Panel Member)
• Lisa Licitra, MD – Fondazione IRCCS Istituto Nazionale dei Tumori (Expert Panel Member)

Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, please visit connected.sitcancer.org, or check out our free CPG mobile app.

The Practical Management Pearls and Case Studies Webinars are part of the Cancer Immunotherapy Clinical Practice Guidelines Advanced Webinar Series supported, in part, by grants from Amgen and Merck & Co., Inc. (as of 9/15/2021).

The SITC Clinical Practice Guidelines are produced by SITC and have no funding from outside sources.